Martha P. Mims
Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Martha P. Mims as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04626024 · Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World PopulationBaylor College of Medicine · active not recruiting · Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission · principal investigator
- Ph2NCT00908219 · A Study of Bevacizumab to Prevent Malignant AscitesBaylor College of Medicine · withdrawn · Malignant Ascites
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical, Protocol, and Data ManagementP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · fiscal years 2007 to 2026 · $366,873 awarded in 2026Same name and institution; not confirmed by an ID
- DMT1:Tissue specific expression & alternative splicingR21DK069851 · NIDDK · BAYLOR COLLEGE OF MEDICINE · fiscal years 2005 to 2006 · $146,475 awarded in 2006Same name and institution; not confirmed by an ID
- DYNAMICS OF APOE BINDING TO LIPOPROTEINS AND RECEPTORSR01HL046860 · NHLBI · BAYLOR COLLEGE OF MEDICINE · fiscal years 1993 to 1997 · $180,695 awarded in 1997Same name and institution; not confirmed by an ID
- ACTIVITY & SPECIFICITY OF LYSOSOMAL ACID LIPASES07RR005425 · NCRR · BAYLOR COLLEGE OF MEDICINE · fiscal years 1989 to 1991Same name and institution; not confirmed by an ID
- STUDIES OF CHOLESTERYL ESTER RICH LIPOPROTEINSF32HL007341 · NHLBI · BAYLOR COLLEGE OF MEDICINE · fiscal years 1985 to 1987 · $26,004 awarded in 1987Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:59 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.Br J Haematol · 201048 citationsRCR 1.2
- Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.Clin Cancer Res · 200830 citationsRCR 0.6
- GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.Clin Cancer Res · 201129 citationsRCR 0.7
- HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.Invest New Drugs · 201425 citationsRCR 0.7